表紙:人工血管:医療機器のパイプライン評価
市場調査レポート
商品コード
346859

人工血管:医療機器のパイプライン評価

Vascular Grafts - Medical Devices Pipeline Assessment, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 85 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.27円
人工血管:医療機器のパイプライン評価
出版日: 2020年10月31日
発行: GlobalData
ページ情報: 英文 85 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、人工血管のパイプライン製品について調査分析し、開発段階別の比較分析に焦点を当てて、パイプライン製品の開発に従事している主要企業、進行中の臨床試験に関する情報なども含めて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 人工血管の概要

第3章 開発中の製品

  • 人工血管 - パイプライン製品:開発段階別
  • 人工血管 - パイプライン製品:地域別
  • 人工血管 - パイプライン製品:規制別
  • 人工血管 - パイプライン製品:承認予定日別
  • 人工血管 - 進行中の臨床試験

第4章 人工血管 - 開発中のパイプライン製品:企業別

  • 人工血管企業 - パイプライン製品:開発段階別
  • 人工血管 - パイプライン製品:開発段階別

第5章 人工血管企業と製品の概要

  • 3S BioMedical, Inc.
  • Anethon (Inactive)
  • ARISTE Medical
  • Cardiojustable LLC
  • CryoLife, Inc.
  • DSM Biomedical B.V.
  • Eqalix, Inc.
  • FIT Biotech Oy
  • Gel-Del Technologies, Inc.
  • Graftworx, LLC
  • Healionics Corporation
  • Innovia LLC
  • MultiGene Vascular Systems (MGVS) Ltd.
  • NuVascular Technologies Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • SurgaColl Technologies Ltd
  • Universidad de Los Andes
  • VesselTek BioMedical LLC
  • Xeltis AG

第6章 人工血管 - 最近の動向

第7章 付録

図表

図表

List of Tables

List of Tables

  • Table 1: Vascular Grafts - Pipeline Products by Stage of Development
  • Table 2: Vascular Grafts - Pipeline Products by Segment
  • Table 3: Vascular Grafts - Pipeline Products by Territory
  • Table 4: Vascular Grafts - Pipeline Products by Regulator

List of Figures

List of Figures

  • Figure 1: Vascular Grafts - Pipeline Products by Stage of Development
  • Figure 2: Vascular Grafts - Pipeline Products by Segment
  • Figure 3: Vascular Grafts - Pipeline Products by Territory
  • Figure 4: Vascular Grafts - Pipeline Products by Regulatory Path
  • Figure 5: Vascular Grafts - Pipeline Products by Estimated Approval Date
  • Figure 6: Vascular Grafts - Ongoing Clinical Trials
目次
Product Code: GDME1015EPD

GlobalData's Medical Devices sector report, "Vascular Grafts - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Vascular Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vascular Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vascular Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Vascular Grafts Overview

3 Products under Development

  • 3.1 Vascular Grafts - Pipeline Products by Stage of Development
  • 3.2 Vascular Grafts - Pipeline Products by Segment
  • 3.3 Vascular Grafts - Pipeline Products by Territory
  • 3.4 Vascular Grafts - Pipeline Products by Regulatory Path
  • 3.5 Vascular Grafts - Pipeline Products by Estimated Approval Date
  • 3.6 Vascular Grafts - Ongoing Clinical Trials

4 Vascular Grafts - Pipeline Products under Development by Companies

  • 4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development
  • 4.2 Vascular Grafts - Pipeline Products by Stage of Development

5 Vascular Grafts Companies and Product Overview

  • 5.1 3DT Holdings LLC Company Overview
    • 5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Andes University Company Overview
    • 5.2.1 Andes University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Angiograft LLC Company Overview
    • 5.3.1 Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Ariste Medical LLC Company Overview
    • 5.4.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Aruga Technologies LLC Company Overview
    • 5.5.1 Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 BioIntegral Surgical Inc Company Overview
    • 5.6.1 BioIntegral Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Biosurfaces Inc Company Overview
    • 5.7.1 Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Cardiojustable LLC (Inactive) Company Overview
    • 5.8.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Cardiovate Company Overview
    • 5.9.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Colorado Therapeutics, LLC Company Overview
    • 5.10.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 CryoLife Inc Company Overview
    • 5.11.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Cytograft Tissue Engineering Inc (Inactive) Company Overview
    • 5.12.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 DSM Biomedical BV Company Overview
    • 5.13.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Eqalix Inc Company Overview
    • 5.14.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 FIT Biotech Oy (Inactive) Company Overview
    • 5.15.1 FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Gel-Del Technologies, Inc. Company Overview
    • 5.16.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Humacyte Inc Company Overview
    • 5.17.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Innovia LLC Company Overview
    • 5.18.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 LeMaitre Vascular Inc Company Overview
    • 5.19.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 Merit Medical Systems Inc Company Overview
    • 5.20.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Nationwide Children's Hospital Company Overview
    • 5.21.1 Nationwide Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Northwestern University Company Overview
    • 5.22.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Peca Labs Inc Company Overview
    • 5.23.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 PetVivo Holdings Inc Company Overview
    • 5.24.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 PQ Bypass Inc Company Overview
    • 5.25.1 PQ Bypass Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 RegenaGraft Company Overview
    • 5.26.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 RUA Vascular Ltd Company Overview
    • 5.27.1 RUA Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Secant Group LLC Company Overview
    • 5.28.1 Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Terumo Aortic Company Overview
    • 5.29.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 Tgen Tech LLC Company Overview
    • 5.30.1 Tgen Tech LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 TTK Healthcare Ltd Company Overview
    • 5.31.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 University of Louisville Company Overview
    • 5.32.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 University of Pittsburgh Company Overview
    • 5.33.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 Vascudyne Inc Company Overview
    • 5.34.1 Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 VenoStent Inc Company Overview
    • 5.35.1 VenoStent Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36 VesselTek BioMedical LLC Company Overview
    • 5.36.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37 VESSL Therapeutics Ltd Company Overview
    • 5.37.1 VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Vascular Grafts- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer